Literature DB >> 3978049

Reduced killer cell activity of lymphocytes from patients with asbestosis.

M Kubota, S Kagamimori, K Yokoyama, A Okada.   

Abstract

Immunological abnormalities in 30 patients with asbestosis were investigated by examining the cytoxicity of natural killer (NK) cells and antibody dependent cellular cytotoxicity by killer (K) cells from peripheral blood lymphocytes; the effects of interferon on NK activity was also examined. Fifteen men and 15 women (mean age 58; range 40-72) with asbestosis but who were free of complications such as tuberculosis, carcinoma, or steroid treatment were the subjects for study. There were nine cases of type 1, 19 cases of type 2, and two cases of type 3 disease as described in the ILO classification of pneumoconiosis. They were all textile workers with a mean duration of 18 years (3-40 years) since first exposure to chrysotile. Controls matched for age and sex were selected from a population without occupational exposure to asbestos. The activity of the NK and K cells in patients with asbestosis was significantly lower than in the control group, but the populations of NK and K cells in the peripheral blood lymphocytes were not significantly different in the two groups. An in vitro experiment showed that the increase in the cytotoxicity of the NK cell after treatment with interferon-alpha was significantly lower in the subjects than in the controls. These results indicate that one of the defence mechanisms in relation to cancer is deficient in patients with asbestosis.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3978049      PMCID: PMC1007469          DOI: 10.1136/oem.42.4.276

Source DB:  PubMed          Journal:  Br J Ind Med        ISSN: 0007-1072


  20 in total

1.  Diffuse pleural mesothelioma and asbestos exposure in the North Western Cape Province.

Authors:  J C WAGNER; C A SLEGGS; P MARCHAND
Journal:  Br J Ind Med       Date:  1960-10

Review 2.  Mechanisms of activation of human natural killer cells against tumor and virus-infected cells.

Authors:  D Santoli; H Koprowski
Journal:  Immunol Rev       Date:  1979       Impact factor: 12.988

3.  Immunology and asbestosis.

Authors:  M Turner-Warwick
Journal:  Proc R Soc Med       Date:  1973-09

4.  Dual mechanism of interferon augmentation of natural killer cytotoxicity (NKCC).

Authors:  S Targan; F Dorey
Journal:  Ann N Y Acad Sci       Date:  1980       Impact factor: 5.691

5.  Immunological studies of patients with asbestosis. II, Studies of circulating lymphoid cell numbers and humoral immunity.

Authors:  E Kagan; A Solomon; J C Cochrane; P Kuba; P H Rocks; I Webster
Journal:  Clin Exp Immunol       Date:  1977-05       Impact factor: 4.330

Review 6.  Natural killer (NK) cells and their possible roles in resistance against disease.

Authors:  R B Herberman
Journal:  Clin Immunol Rev       Date:  1981

7.  Interferon production of vitro by leucocytes from patients with systemic lupus erythematosus and rheumatoid arthritis.

Authors:  P A Neighbour; A I Grayzel
Journal:  Clin Exp Immunol       Date:  1981-09       Impact factor: 4.330

8.  Lack of correlation between impaired interferon production and natural killer activity of lymphocytes in multiple sclerosis.

Authors:  I Stöger; M Tálas; M Benczúr; E Gyódi; G G Petrányi; G Pálffy; B Kotsy
Journal:  Arch Virol       Date:  1982       Impact factor: 2.574

9.  The interferon system in patients with malignant disease.

Authors:  T Hahn; S Levin
Journal:  J Interferon Res       Date:  1982

10.  Anti-viral activity induced by culturing lymphocytes with tumor-derived or virus-transformed cells. Enhancement of human natural killer cell activity by interferon and antagonistic inhibition of susceptibility of target cells to lysis.

Authors:  G Trinchieri; D Santoli
Journal:  J Exp Med       Date:  1978-05-01       Impact factor: 14.307

View more
  6 in total

1.  Lymphocyte subsets in subjects exposed to asbestos: changes in circulating natural killer cells.

Authors:  N al Jarad; M Macey; S Uthayakumar; A C Newland; R M Rudd
Journal:  Br J Ind Med       Date:  1992-11

Review 2.  Malignant mesothelioma.

Authors:  R Rudd
Journal:  J R Soc Med       Date:  1989-03       Impact factor: 5.344

3.  High frequency of immune dysfunctions in asbestos workers and in patients with malignant mesothelioma.

Authors:  F Lew; P Tsang; J F Holland; N Warner; I J Selikoff; J G Bekesi
Journal:  J Clin Immunol       Date:  1986-05       Impact factor: 8.317

4.  Immune response in shipyard workers with x ray abnormalities consistent with asbestos exposure.

Authors:  H Anton-Culver; B D Culver; T Kurosaki
Journal:  Br J Ind Med       Date:  1988-07

Review 5.  Selected new developments in asbestos immunotoxicity.

Authors:  G J Rosenthal; E Corsini; P Simeonova
Journal:  Environ Health Perspect       Date:  1998-02       Impact factor: 9.031

6.  Asbestos fibres inhibit the in vitro activity of lymphokine-activated killer (LAK) cells from healthy individuals and patients with malignant mesothelioma.

Authors:  L S Manning; M R Davis; B W Robinson
Journal:  Clin Exp Immunol       Date:  1991-01       Impact factor: 4.330

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.